Analysis of outcomes and renal recovery after adult living‐donor liver transplantation among recipients with hepatorenal syndrome

When timely access to deceased‐donor livers is not feasible, living‐donor liver transplantation (LDLT) is an attractive option for patients with hepatorenal syndrome (HRS). This study's primary objective was to describe outcomes after LDLT among HRS recipients, and the secondary objective was t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of transplantation 2022-10, Vol.22 (10), p.2381-2391
Hauptverfasser:	Park, Cheon‐Soo, Yoon, Young‐In, Kim, Nayoung, Hwang, Shin, Ha, Tae‐Yong, Jung, Dong‐Hwan, Song, Gi‐Won, Moon, Deok‐Bog, Ahn, Chul‐Soo, Park, Gil‐Chun, Kim, Ki‐Hun, Cho, Yong‐Pil, Lee, Sung‐Gyu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Blood & organ donations Clinical outcomes Creatinine Diabetes mellitus end‐stage liver disease Hepatorenal Syndrome - surgery Humans Kidneys Liver diseases Liver Transplantation Liver transplants Living Donors Medical prognosis prognosis Recovery (Medical) renal recovery Retrospective Studies Sepsis serum creatinine Survival Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	When timely access to deceased‐donor livers is not feasible, living‐donor liver transplantation (LDLT) is an attractive option for patients with hepatorenal syndrome (HRS). This study's primary objective was to describe outcomes after LDLT among HRS recipients, and the secondary objective was to determine predictors of poor renal recovery after LDLT. This single‐center, retrospective study included 2185 LDLT recipients divided into HRS (n = 126, 5.8%) and non‐HRS (n = 2059, 94.2%) groups. The study outcomes were survival and post‐LT renal recovery. The HRS group had a higher death rate than the non‐HRS group (17.5% vs. 8.6%, p
ISSN:	1600-6135 1600-6143
DOI:	10.1111/ajt.17105